Park City, UT

3 days / 6 sessions
Current Issues in Spine

February 2-4, 2017

SpineVision® Receives CE Mark for Next-Gen P.L.U.S.® Deformity-Correction Spinal System

September 18, 2018 by OrthoSpineNews
SpineVision_Product_Plus02-1212bto-1.jpg

ANTONY, France–(BUSINESS WIRE)–SpineVision announced today that it has received CE mark for its next-generation Pivot Link Universal System (P.L.U.S.) spine deformity-correction system. SpineVision will introduce the next-generation P.L.U.S. to spine surgeons at “EuroSpine 2018” (Booth #24C) in Barcelona, Spain (Sept. 19-21), and “NASS 2018” (Booth #1311) in Los Angeles (Sept. 26-29).

Deformity of the spine includes any abnormality of the formation, alignment, or shape of the vertebral column. Diagnoses that are associated with spine deformity include scoliosisspina bifidaBecker and Duchenne muscular dystrophykyphosis, and spondylolisthesis, among others. Spine stabilization surgery is recommended in cases where there is severe pain, neurological problems, or curvature greater than 50 degrees. The goal of surgery is to straighten and hold the spine straight. Several surgical techniques can be used, including spinal fusion and the use of implants such as the P.L.U.S. to secure the fusion.

“The introduction of our Pivot Link Universal System (P.L.U.S.) extends our successful track record of commercializing cutting-edge products encompassing all spine pathologies,” said Arnaud Brisard, CEO of SpineVision. “We believe that this next generation of an already successful product will be enthusiastically embraced by orthopedic surgeons, because the P.L.U.S. is designed to make every step of spine deformity surgery more facile for the orthopedic surgeon—especially correction maneuvers before final locking.”

CLICK HERE FOR THE COMPLETE VERSION OF THIS NEWS RELEASE.

Contacts

Ronald Trahan Associates Inc.
Ronald Trahan, APR, +1 508-816-6730
rtrahan@ronaldtrahan.com

OrthoSpineNews

OrthoSpineNews.com is the preferred aggregator of all news in the orthopedic and spine industry. You can subscribe for our daily email, follow us on twitter or download our app for iPhone and Android.